Skip to content
OpenCapital
Get started

Anterix ATEX Acquired in-process research and development

Acquired in-process research and development at other companies

ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$684.75K—

Other financials

Income statement

See full
Revenue$2.0M+41.0%
Gross profit$608.0K+81.5%
Operating income$19.8M—
Net income$18.5M—
EPS (diluted)$0.98—

Balance sheet

See full
Cash & equivalents$98.5M+108%
Total debt$4.4M-18.0%
Total equity$262.3M+67.5%
Total assets$465.2M+39.7%

Cash flow

See full
Operating cash flow$15.5M+194%
CapEx$22.0K-52.2%
Free cash flow$15.5M+193%

Valuation

See full
Market cap$1.5B+190%
Enterprise value$1.4B+196%
P/E16.5×—
P/S230.1×+145×

Profitability

See full
Gross margin-105.3%—
Operating margin1,444.9%—
Net margin1,394.2%—
FCF margin-486.7%-1,481pp

Returns & leverage

See full
Return on equity43.3%—
Debt / equity0×0.0×
Current ratio3.3×+1.1×

Where this comes from

Reported directly by Anterix in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfIntangibleAssets.

The official record: Anterix’s 10-K, filed June 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anterix's acquired in-process research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anterix's acquired in-process research and development?
Anterix (ATEX) reported acquired in-process research and development of $53.5M in Q1 2026.
How has Anterix's acquired in-process research and development changed year-over-year?
Anterix's acquired in-process research and development increased by 30.7% year-over-year, from $40.94M to $53.5M.
What does acquired in-process research and development mean?
Represents the cash outflow associated with the acquisition of in-process research and development assets from third parties. This metric highlights the company's strategy for inorganic growth and its commitment to investing in future technological capabilities. It is a vital indicator of capital allocation toward innovation and long-term product development.